Introduction
Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) remains a major public health problem globally. Although TB is a preventable and curable disease, the World Health Organization (WHO) estimated that 10.4 million new cases occurred around the world in 2015 alone, and that 1.4 million of these cases resulted in death (WHO, 2016) . The majority of deaths were reported in developing countries, with more than half occurring in Asia (58%).
Nepal is one of the Asian countries that experiences a large number of TB cases every year. For example, in 2015, Nepal reported a TB mortality rate of 21%, and estimates of TB prevalence and incidence were 215 and 156, respectively, per 100 000 inhabitants (WHO, 2016) . Furthermore, despite a TB control program run by the government, the number of TB cases in Nepal has not decreased over the last decade. The reason behind this phenomenon remains unknown; thus, comprehensive studies on MTB transmission in Nepal are needed.
Genotyping of MTB isolates has proven to be a powerful tool for investigating suspected outbreaks, the source of transmission, the transmission chain, and circulating strains (Crawford, 2003) .
Spoligotyping (Kamerbeek et al., 1997) , mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) analysis (Supply et al., 2006) , and IS6110 restriction fragment length polymorphism (RFLP) typing (Beggs et al., 2000) are commonly used techniques for genotyping. However, IS6110 RFLP typing is a time-consuming technique and the comparison of results between laboratories is difficult (Varma-Basil et al., 2011) . As a result, spoligotyping and MIRU-VNTR have more often been used in recent molecular epidemiological studies. Moreover, both of these genotyping methods are reliable, discriminative, and technically feasible for comparisons between laboratories (Mazars et al., 2001) .
MTB consists of four major lineages based on specific genetic markers and geographical areas: lineage 1 (Indo-Oceanic lineage), lineage 2 (East-Asian Lineage, includes Beijing family), lineage 3 (East African Indian, includes Delhi/CAS family), and lineage 4 (Euro-American lineage) (Comas et al., 2009; Filliol et al., 2003; Gagneux et al., 2006) . Previous studies on the genotype of MTB isolates in Nepalese patients reported the lineage 3 Central Asian Strain (CAS) family as the dominant family in Nepal (Malla et al., 2012) . Other studies have also reported the CAS family as dominant (Ali et al., 2007; Hasan et al., 2006; Singh et al., 2007; Singh et al., 2015) and to be a contributor to multidrug resistance (MDR) in TB in South Asian countries (Yasmin et al., 2014) . For instance, in India, Stavrum et al. (2009) associated the CAS family with multidrug-resistant tuberculosis (MDR-TB), and in Pakistan it was linked to the increasing prevalence of MDR-TB and emergence of extensively drug-resistant (XDR) TB (Hasan et al., 2010) . It is believed, therefore, that the emergence of MDR-MTB in the CAS family poses a serious threat to the success of TB control programs in the region. Likewise, in Nepal, MDR-MTB is considered to be one of the major emerging threats to the success of TB control. For instance, in 2010, a study conducted in Nepal showed an MDR-MTB prevalence of 11.7% in re-treated cases (NTPN, 2010) , but the latest national anti-TB drug resistance survey conducted between 2011 and 2012 showed that MDR-MTB prevalence increased to 15.4% in re-treated cases (NTPN, 2014) . Nonetheless, a study is yet to be conducted in Nepal to determine the genetic characteristics of MDR in MTB of the CAS family.
The main purpose of the present study was to conduct a genetic analysis of MDR in MTB of the CAS family and to understand its molecular epidemiological features and transmission dynamics in Nepalese TB patients.
Materials and methods

Sample collection and drug susceptibility testing
A total of 601 MDR-MTB isolates collected from April 2008 to March 2013 by the German Nepal Tuberculosis Project (GENETUP) were used, of which 145 MDR-MTB CAS family isolates were purposively selected. Isolates were collected from a decentralized National Tuberculosis Program (NTP) network of 11 MDR-TB treatment centers and 66 sub-treatment centers. The location of treatment centers and the number of samples collected from each center are shown in Figure S1 in the Supplementary Material in the online version, at http://dx.doi.org/10.1016/j.ijid.2017.06.010. All samples were obtained from different individuals. Epidemiological features of patients were also collected from hospital medical records. A phenotypic drug susceptibility test (DST) was performed using the proportional method on Löwenstein-Jensen (LJ) medium with standard critical concentrations for isoniazid (INH) (0.2 mg/ml), rifampicin (RIF) (40 mg/ml), streptomycin (STR) (4 mg/ml), and ethambutol (EMB) (2 mg/ml) (WHO, 2009 ).
DNA extraction
Mycobacterial colonies on positive LJ cultures were suspended in 300 ml of distilled water and heated for 20 min at 95 C. Heated samples were sonicated in an ultrasonic water bath apparatus (Elma Hans Schmidbauer GmbH & Co. KG, Germany) for 15 min and centrifuged for 5 min at 10 000 Â g. Next, the bacterial DNAcontaining supernatant was retrieved and used for further molecular analysis.
Spoligotyping
All isolates were analyzed by spoligotyping, as described by Kamerbeek et al. (1997) . Briefly, the direct repeat (DR) region was amplified with a pair of primers, and the resulting PCR products were hybridized to a set of 43 spacer-specific oligonucleotide probes, which were immobilized on the membrane. Spoligotyping data were analyzed using the SITVIT database (http://www. pasteur-guadeloupe.fr:8081/SITVIT_ONLINE/) to determine the spoligotype international type (SIT) (Demay et al., 2012) .
MIRU-VNTR typing
MIRU-VNTR typing was performed by amplifying 24 loci, including 12 MIRU loci (MIRU2, MIRU4, MIRU10, MIRU16, MIRU20, MIRU23, MIRU24, MIRU26, MIRU27, MIRU31, MIRU39, and MIRU40), four exact tandem repeat (ETR) loci (ETR-A, ETR-B, ETR-C, and ETR-F), four Queens University Belfast (QUB) loci (QUB11a, QUB11b, QUB26, and QUB4156), and four VNTR loci (VNTR424, VNTR1955, VNTR2401, and VNTR3690), as described by Supply et al. (2006) .
Sequencing of drug resistance-associated genes
Isolates clustered by a combined analysis of spoligotyping and MIRU-VNTR typing were analyzed further by sequencing of the drug resistance-associated genes, i.e. rifampicin resistance determining region (RRDR) in rpoB for RIF resistance and katG coding and inhA promoter regions for INH resistance, as described previously (Poudel et al., 2012) .
Data management and analysis
Demographic data including age, sex, and treatment history for TB were analyzed using IBM SPSS Statistics version 19.0 (IBM Corp., Armonk, NY, USA) and PRISM version 5 (GraphPad Software, Inc., La Jolla, CA, USA). Individual and cumulative Hunter Gaston Discriminatory Indices (HGDI) were calculated to determine the discriminatory power of each MIRU-VNTR locus and overall loci (Hunter and Gaston, 1988) . The discriminatory power of each locus was considered high (HGDI > 0.6), moderate (0.3 HGDI 0.6), or poor (HGDI < 0.3), as suggested by Sola et al. (2003) . A cluster was defined as two or more isolates sharing an identical spoligotype and MIRU-VNTR pattern, and the clustering rate was calculated using the formula 'number of clustered isolates'/'total number of isolates' (Glynn et al., 1999) . A phylogenetic tree was constructed by unweighted pair group method with arithmetic mean (UPGMA) using an online MIRU-VNTRplus Web-based application (http:// www.miru-vntrplus.org) (Weniger et al., 2010) .
Results
Demographic information
Age, sex, and treatment history information of patients from whom 145 CAS and 456 non-CAS MDR isolates were obtained were compared (Table 1) . Regarding the age group, a significant difference was found between those aged 0-20 years and those aged >60 years (p < 0.05, Chi-square test). There were no other factors significantly associated with the CAS isolate infection among MDR-TB patients.
Spoligotype
A total of 145 MDR CAS isolates were divided into 25 spoligotype patterns, and CAS1_Delhi SIT26 was found to be most prevalent (60/145, 41.4%), followed by CAS SIT599 (15/145, 10.3%) and CAS SIT357 (9/145, 6.2%), as listed in Table 2 .
MIRU-VNTR
Allelic diversity of each MIRU-VNTR locus and HGDI are shown in Table 3 . Three out of 24 loci (QUB26, MIRU10, and VNTR424) were found to be highly discriminant, 11 loci (MIRU26, VNTR3960, MIRU31, MIRU40, ETR-A, QUB11a, QUB4156, VNTR2401, VNTR1955, MIRU39, and ETR-F) were moderately discriminant, and the remaining 10 loci were poorly discriminant.
The number of MIRU-VNTR patterns with the 24 loci was 107, including 21 clusters that consisted of 54 isolates (clustering rate 37.2%) ( Table 4 ). The cumulative HGDI of VNTR with all 24 loci was equal to that of MIRU-VNTR with the top 15 loci (HGDI 0.9942). As CAS1_Delhi SIT26, the dominant type in the MDR CAS family, consisted of 60 isolates, its MIRU-VNTR allelic diversity was also analyzed in the same manner. The results were similar to those of the total MDR CAS family and the cumulative HGDI reached the maximum with almost the same top 15 loci (Supplementary Material, Table S1 in the online version at DOI: 10.1016/j.ijid.2017.06.010).
By combining the analysis of spoligotyping and MIRU-VNTR, 18 clusters were found, consisting of 47 isolates with an identical pattern in each cluster. The clustering rate was 32.4%, and the biggest cluster consisted of six isolates, followed by three fourisolate clusters, one three-isolate cluster, and finally 13 clusters consisting of two isolates ( Figure 1 , Table 5 ).
Sequence analysis of drug resistance-associated genes
Clustered isolates were analyzed further by sequencing the drug resistance-associated genes (rpoB, katG coding, and inhA promoter region) to identify possible MDR-MTB transmission (Table 5) . Among the 47 isolates, all but one had the G944C mutation (i.e., Ser315Thr substitution) in katG, which is a wellknown INH resistance-associated mutation. In the rpoB analysis, 45 isolates had a mutation or deletion in RRDR, and C1349T (Ser531Leu) was dominant (20/47, 42.6%). Among the 18 clusters, 14 had isolates sharing the same rpoB mutation, and half of them were the major substitution Ser531Leu. Among the remaining clusters, cluster 1 isolates shared the same three-codon deletion in which the deletion pattern was identical. In the biggest cluster, cluster 13, four isolates shared the same substitution His526Asp and two of them had a mutation T-8C in the inhA promoter region. In cluster 6 and cluster 14, two isolates each shared a rare substitution, Asp516Phe (GAC ! TTC) and Ser531Gln (TCG ! CAG), respectively, both of which require a double mutation in a codon. In cluster 17, all four isolates shared a relatively rare substitution, Gln513Leu; moreover, the substitution Leu511Pro shared in cluster 11 was also rare. Most of the isolates sharing rare mutations were restricted to the same geographic locations (Table 5) ; however, none of these patients had been in personal contact with the others sharing the genetically same bacteria. Other demographic features can also be found in Table 5 .
Discussion
This study is the first to demonstrate the genetic characteristics of MDR CAS isolates in Nepal and their high diversity is shown. The CAS family is reported as being highly prevalent among TB patients in certain regions of the Indian subcontinent, namely, Pakistan and the northern half of India (Hasan et al., 2006; Singh et al., 2007; Singh et al., 2015) . Geographically, Nepal is located between two greatly TB-burdened countries, India and China, which contribute one third of the world's TB cases. Historically, Nepal has had an open border with India, and both Nepalese and Indian citizens often visit the bordering area for work, pilgrimage, and education. This regular interaction may provide the opportunity for direct transmission of the CAS family MTB between the Indian and Nepalese populations.
In the present study, the ratio of MDR-TB patients infected with the CAS family was higher in the age group >60 years than in the younger groups (odds ratio 3.25 compared to the 0-20 years age group; p < 0.05, Table 1 ). This association between the CAS family and elderly people might be related to the historical prevalence of CAS in Nepal and caused by reactivation of latent TB infection. However, when comparing the patient age distribution of clustered (n = 47) and non-clustered (n = 98) isolates, it was found that the average age of the clustered isolate-infected patients was significantly lower than that of the non-clustered group (t-test, Table 5 Demographic information of patients and genetic characteristics of the 47 MDR-MTB clustered isolates belonging to the CAS genotype.
MDR-MTB, multidrug-resistant Mycobacterium tuberculosis; MIRU-VNTR, mycobacterial interspersed repetitive unit-variable number tandem repeat; M, male; F, female. a CAT II failure: patients who were either smear-positive relapse, chronic, MDR contact, relapse, or treatment after default. CAT I failure: failure in new cases of smear-positive pulmonary TB. b SIT (spoligotype international types) were assigned by SITVITWEB database and MIRU-VNTR plus Web tool. c Order of loci: MIRU2, VNTR424, ETR-C, MIRU4, MIRU40, MIRU10, MIRU16, VNTR1955, MIRU20, QUB11b, ETR-A, QUB11a, VNTR2401, ETR-B, MIRU23, MIRU24, MIRU26, MIRU27, ETR-F, MIRU31, VNTR3690, QUB26, QUB4156, and MIRU39. d Drug susceptibility test results. Isolates showed resistance against R (rifampicin), I (isoniazid), S (streptomycin), E (ethambutol). e Amino acid substitutions are shown in the codon number. Del: deletion; À: PCR failed; WT: wild-type sequence. KatG Ser 315 Thr substitution was by katG G944C mutation. p < 0.05). This may suggest that younger generations were more likely to be infected with clustered isolates, indicating that these cases were the outcome of recent transmissions (Supplementary Material, Figure S2 in the online version, at http://dx.doi.org/ 10.1016/j.ijid.2017.06.010). This phenomenon may be explained by the higher social activity of younger generations compared with older generations, which likely contributes to a higher transmission risk.
It was found that spoligotyping alone could not identify diversity in the CAS family in Nepal due to the dominant cluster of CAS1_Delhi SIT26 contributing 60 isolates (Table 2) . However, all 145 MDR CAS family isolates were successfully differentiated into 116 patterns including 18 clusters (clustering rate 32.4%) by combining spoligotyping and 24-locus MIRU-VNTR analysis (Figure 1 ). The optimization of these MIRU-VNTR loci was further investigated. As expected, it was possible to select an affordable locus set, as suggested by the authors of previous studies (Diab et al., 2016; Wang et al., 2011) . Based on the cumulative HGDI analysis of 24 loci with clustering rates (Table 4) , a set of 15 loci was shown to have the same discriminatory power as 24 loci. To obtain higher discriminatory power, two of the 24 loci reported by Supply et al. (2006) were replaced: Mtub29 and Mtub34, with ETR-F and QUB11a. Both of the newly replaced loci were listed among the top 15 discriminant loci that successfully worked for the Nepali MDR CAS cases (Table 4 ; Supplementary Material, Table S1 ). To save time and cost, smaller locus numbers of VNTR are better than larger numbers, even though MIRU-VNTR analysis may be more feasible at local research centers than other typing methods.
In addition, it was possible to discriminate clustered MDR isolates by conducting sequencing analysis of drug resistanceassociated genes, katG, rpoB, and inhA promoter region. The katG 315 substitution is an INH resistance-associated mutation well known for its low fitness cost (van Soolingen et al., 2000) . However, in highly TB-burdened countries, the majority of INHresistant MTB isolates have this mutation, thus it cannot be used as a transmission marker, although it can still be used as a genetic marker of INH resistance (Aye et al., 2016; Poudel et al., 2012; Rahim et al., 2012) . In contrast, rpoB mutations can be a good marker for MDR-TB transmission, as the variation in RIF resistanceassociated mutation in RRDR is much higher than katG in highly TB-burdened countries (Aye et al., 2016; Poudel et al., 2012; Rahim et al., 2012) . Having a mutation in RRDR strongly suggests that the isolate is RIF-resistant. RNA polymerase is an essential enzyme for bacteria, thus the majority of non-synonymous mutations in RRDR deteriorate, and frequently observed mutations in RIF-resistant MTB are limited. Even such 'acceptable' amino acid substitutions still exert adverse effects on the enzyme function; therefore, RRDR mutated survivors tend to have additional mutations known as 'compensatory mutations' inside the RRDR or nearby RNA polymerase components (de Vos et al., 2013) .
In this study, two double mutations that occurred in one codon were found. One of them, Asp516Phe (GAC ! TTC), found in clusters 6 and 7, may be an example of the aforementioned compensatory mutations, as the possible parent mutant Asp516Val (GAC ! GTC) was found in both clusters (Table 5 ). As clusters 6 and 7 were different by only one locus with high polymorphism (MIRU10) in the lineage in MIRU-VNTR (Table 3) , and all isolates were obtained from the same geographic location, the original MDR-MTB bearing Asp516Val might be spread throughout this area. As a result, some of the descendent bacteria may have acquired an additional mutation in the same codon, possibly due to the above-mentioned compensatory mutation, which may have been most suitable for the Asp516Val mutant. Since the variety of the compensatory mutation is also high in RRDR mutant cases (de Vos et al., 2013), the combined analysis of these regions may improve the detection rate of MDR-MTB transmissions.
Several complete matches of genotype, geographic location, and drug resistance-associated mutations were found between two or more isolates in some clusters, suggesting possible transmissions of MDR-MTB between individuals (Table 5 ). In particular, sharing a rare rpoB mutation in the cluster strongly suggested the acquisition of MDR-MTB via person-to-person contact. It was not possible to identify the exact epidemiological link between these patients, which suggests that a common transmission source may exist in the geographic area. In some cases, isolates were obtained from patients living in distant areas. For example, in the case of cluster 17, four isolates were collected in three different areas, Dharan (East), Nepalgunj (Mid West), and Kathmandu (Central), which are as far apart as 200-600 km. In this cluster, the first case was an old man in Kathmandu in 2009, and the remaining were young people visiting hospitals in each area later on. In the case of the patient in the Eastern area of Dharan, it was a new case of MDR-MTB that showed the same four-drug resistance as the others prior to TB treatment ( Table 5 ). As Kathmandu is the capital city, people frequently visit from different areas of Nepal, and thus the city could be a site for transmission of infectious diseases (Poudel et al., 2013) . This hypothesis, however, requires validation by further whole genome sequencing analysis.
The application of combined analysis of spoligotyping and MIRU-VNTR typing together with rpoB sequencing is considered an effective approach to determine the molecular epidemiology of MDR-MTB. The molecular analysis demonstrated that the MDR CAS family is highly diverse in Nepal, which suggests that the bacteria progressively acquired drug resistance and ultimately became MDR in each patient. Nonetheless, the characteristics of some clusters showed evidence of actual MDR-MTB transmission.
A large MDR-MTB outbreak would be more likely to occur among the Nepalese population if transmission trends observed in the present study grew out of control. Thus, the results highlight the importance of laboratory diagnosis of TB, intensified finding of cases, and timely and appropriate treatment of TB patients to cut the transmission chain. It is believed that the proposed 15-locus MIRU-VNTR typing scheme is well suited to assess the population structure of the MDR CAS family and trace back the transmission dynamics in Nepal. The results from the present study will likely contribute to improve epidemiological surveillance, which in turn could lead to the implementation of more effective control measures against the spread of MDR-MTB in Nepal and surrounding countries. 
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